You are here: Welcome » Scott Klarenbach

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
scott_klarenbach [2022/10/25 06:49]
liam 		scott_klarenbach [2022/10/26 23:16] (current)
liam
Line 3: Line 3:
 {{ ::scottklarenbach.jpeg?200|}} {{ ::scottklarenbach.jpeg?200|}}
  
-Dr. **Scott Klarenbach**, MD, MSc, FRCPC is a Canadian nephrologist.+Dr. **Scott Klarenbach**, MD, MSc, FRCPC is a Canadian nephrologist. He is co-chair of the [[AHS COVID-19 Scientific Advisory Group]] under [[Alberta Health Services]]. 
 + 
 +===== Education ===== 
 + 
 +Klarenbach received his medical training at the [[University of Alberta]], and completed his Master of Science in Health Economics at the [[University of York]].((//Profile | Dr. Scott Klarenbach.// University of Alberta. Retrieved October 25, 2022, from https://web.archive.org/web/20221025045508/https://www.ualberta.ca/medicine/about/people/details.html?n=scott-klarenbach#Grants))
  
 ===== Career ===== ===== Career =====
Line 9: Line 13:
 ==== Affiliations ==== ==== Affiliations ====
  
-Klarenbach's professional affiliations include:((//Scott Klarenbach.// Canadian Task Force on Preventative Health Care. Retrieved October 25, 2022, from https://archive.ph/isqlt))+Klarenbach's professional affiliations include:((//Scott Klarenbach.// Canadian Task Force on Preventative Health Care. Retrieved October 25, 2022, from https://archive.ph/isqlt)) ((//Profile | Dr. Scott Klarenbach.// University of Alberta. Retrieved October 25, 2022, from https://web.archive.org/web/20221025045508/https://www.ualberta.ca/medicine/about/people/details.html?n=scott-klarenbach#Grants))
  
   * [[Alberta Drug and Therapeutic Evaluation Consortium]] - Director   * [[Alberta Drug and Therapeutic Evaluation Consortium]] - Director
 +  * [[Canadian Organ Replacement Registry Board]] - President
 +  * [[Canadian Society of Nephrology]] - Chair of the Clinical Practice Guideline Committee
   * [[Canadian Task Force on Preventative Health Care]] - Vice-Chair   * [[Canadian Task Force on Preventative Health Care]] - Vice-Chair
   * [[Kidney Health Strategic Clinical Network]] - Scientific Director   * [[Kidney Health Strategic Clinical Network]] - Scientific Director
Line 18: Line 24:
 === Real-World Evidence Consortium === === Real-World Evidence Consortium ===
  
-Klarenbach is Director of the [[Real-World Evidence Consortium]] at the [[University of Calgary]], which conducts pharmacoepidemiologic and pharmacoeconomic research.((Klarenbach, S. (2022, May 12). //Disclosure Form.// Canadian Task Force on Preventative Health Care. https://web.archive.org/web/20221025043248/https://canadiantaskforce.ca/wp-content/uploads/2022/06/Disclosure-June2022-Klarenbach.pdf)) In his declaration of interest from June 2022, Klarenbach noted that the success of RWEC "is contingent on industry funding", though he doesn't receive any honoraria himself.+Klarenbach is Director of the [[Alberta Real-World Evidence Consortium]] at the [[University of Calgary]], which conducts pharmacoepidemiologic and pharmacoeconomic research.((Klarenbach, S. (2022, May 12). //Disclosure Form.// Canadian Task Force on Preventative Health Care. https://web.archive.org/web/20221025043248/https://canadiantaskforce.ca/wp-content/uploads/2022/06/Disclosure-June2022-Klarenbach.pdf)) In his declaration of interest from June 2022, Klarenbach noted that the success of RWEC "is contingent on industry funding", though he doesn't receive any honoraria himself.
  
 ==== Research ==== ==== Research ====
  
 Klarenbach has published research funded by the [[Public Health Agency of Canada]] through the [[Jewish General Hospital]].((Beck, A., Persaud, N., Tessier, L. A., Grad, R., Kidd, M. R., Klarenbach, S., Korownyk, C., Moore, A., Thombs, B. D., Mangin, D., McCracken, R. K., McDonald, E. G., Sirois, C., Kanji, S., Molnar, F., Nicholls, S. G., Thavorn, K., Bennett, A., Shaver, N., & Skidmore, B. (2022). //Interventions to address potentially inappropriate prescriptions and over-the-counter medication use among adults 65 years and older in primary care settings: protocol for a systematic review.// Systematic Reviews, 11(1). https://doi.org/10.1186/s13643-022-02044-w)) Klarenbach has published research funded by the [[Public Health Agency of Canada]] through the [[Jewish General Hospital]].((Beck, A., Persaud, N., Tessier, L. A., Grad, R., Kidd, M. R., Klarenbach, S., Korownyk, C., Moore, A., Thombs, B. D., Mangin, D., McCracken, R. K., McDonald, E. G., Sirois, C., Kanji, S., Molnar, F., Nicholls, S. G., Thavorn, K., Bennett, A., Shaver, N., & Skidmore, B. (2022). //Interventions to address potentially inappropriate prescriptions and over-the-counter medication use among adults 65 years and older in primary care settings: protocol for a systematic review.// Systematic Reviews, 11(1). https://doi.org/10.1186/s13643-022-02044-w))
 +
 +Additional grants involving Klarenbach as Principal or co-Principal Investigator have come from:((//Profile | Dr. Scott Klarenbach.// University of Alberta. Retrieved October 25, 2022, from https://web.archive.org/web/20221025045508/https://www.ualberta.ca/medicine/about/people/details.html?n=scott-klarenbach#Grants))
 +
 +  * [[Alberta Health Services]] (AHS)
 +  * [[Alberta Innovates]]
 +  * [[Canadian Agency for Drugs and Technology in Health]] (CADTH)
 +  * [[Canadian Institutes of Health Research]] (CIHR)
 +  * [[Institute of Health Economics]] (IHE)
 +  * [[Interdisciplinary Chronic Disease Collaboration]] (ICDC)
 +  * [[Kidney Health Research Group]] (KHRG)
 +  * [[Lawson Health Research Institute]]
 +  * [[University Hospital Foundation]] (UHF)
Back to top